Johnson & Johnson to offer four prescription medicines on TrumpRx website - Reuters
Johnson & Johnson to offer four prescription medicines on TrumpRx website Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5wFBVV95cUxOaGtIbmpWRkJrNVh6bEg2TXlqOTVqY2pnU1FVWGFCNWVaeS1NN3dZbG5zM3RKM2RDWjVsNmRiZk50eWppT0E5VlZPdmNGN3JqVDFURTY5NWRwczdGajRRYi11Z1VBcEZ2UEtBYmlReGxOdl9HS1p5TTZtcnNGVVdLd0pVckV3SXpETHZIYTJzWE92WXZacE43Uk9EVVlZM1lVRDJyTVJyU0pYVmRxQ1BzcEhZaVFkQm9wNHpMLU5lMGRXc1VMZlZnZXNDRXpYUDg0ekpHN3c4M3o3Rzc1cUdCNHZTYVF1UXc?oc=5" target="_blank">Johnson & Johnson to offer four prescription medicines on TrumpRx website</a> <font color="#6f6f6f">Reuters</font>
Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto.
Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website, including metformin, Invokana, and Xarelto.
Johnson & Johnson will start marketing four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto.
Johnson & Johnson will officially start marketing four of its medications on the Trump administration's TrumpRx website, including metformin, Invokana, and Xarelto.
Johnson & Johnson will start selling four of its medications on the Trump administration's TrumpRx website, including diabetes drugs Invokamet, Invokamet XR, Invokana, and blood thinner Xarelto, as part of an agreement to reduce drug prices for Americans.
Similar Stories
Related coverage based on topic and tags
China approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
August 27, 2026 at 05:02 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS health department seeks public feedback on vaccine guidelines after Trump order - Reuters
US health department seeks public feedback on vaccine guidelines after Trump order Reuters
August 21, 2026 at 06:59 PMHuawei plans for more AI pharma tie-ups, says healthcare president - Reuters
Huawei plans for more AI pharma tie-ups, says healthcare president Reuters
August 27, 2026 at 08:27 AMThree scientists beat J&J's defamation suit over talc research - Reuters
Three scientists beat J&J's defamation suit over talc research Reuters
August 21, 2026 at 04:31 PMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PM